Correlation Between Cns Pharmaceuticals and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cns Pharmaceuticals and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cns Pharmaceuticals and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cns Pharmaceuticals and ZyVersa Therapeutics, you can compare the effects of market volatilities on Cns Pharmaceuticals and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cns Pharmaceuticals with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cns Pharmaceuticals and ZyVersa Therapeutics.
Diversification Opportunities for Cns Pharmaceuticals and ZyVersa Therapeutics
0.62 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cns and ZyVersa is 0.62. Overlapping area represents the amount of risk that can be diversified away by holding Cns Pharmaceuticals and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Cns Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cns Pharmaceuticals are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Cns Pharmaceuticals i.e., Cns Pharmaceuticals and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Cns Pharmaceuticals and ZyVersa Therapeutics
Given the investment horizon of 90 days Cns Pharmaceuticals is expected to under-perform the ZyVersa Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Cns Pharmaceuticals is 1.39 times less risky than ZyVersa Therapeutics. The stock trades about -0.02 of its potential returns per unit of risk. The ZyVersa Therapeutics is currently generating about -0.02 of returns per unit of risk over similar time horizon. If you would invest 620.00 in ZyVersa Therapeutics on February 22, 2024 and sell it today you would lose (180.00) from holding ZyVersa Therapeutics or give up 29.03% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Cns Pharmaceuticals vs. ZyVersa Therapeutics
Performance |
Timeline |
Cns Pharmaceuticals |
ZyVersa Therapeutics |
Cns Pharmaceuticals and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Cns Pharmaceuticals and ZyVersa Therapeutics
The main advantage of trading using opposite Cns Pharmaceuticals and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cns Pharmaceuticals position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.Cns Pharmaceuticals vs. Morningstar Unconstrained Allocation | Cns Pharmaceuticals vs. Victory Sophus Emerging | Cns Pharmaceuticals vs. Spring Valley Acquisition | Cns Pharmaceuticals vs. CarMax Inc |
ZyVersa Therapeutics vs. Morningstar Unconstrained Allocation | ZyVersa Therapeutics vs. Victory Sophus Emerging | ZyVersa Therapeutics vs. Spring Valley Acquisition | ZyVersa Therapeutics vs. CarMax Inc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Complementary Tools
Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Commodity Directory Find actively traded commodities issued by global exchanges |